Radiation Oncology/Therapy: Page 183

Proton therapy groups praise GAO prostate cancer report

By AuntMinnie.com staff writers

Two groups representing the proton therapy community issued a statement backing a recent report from the U.S. Government Accountability Office (GAO) that highlighted a trend toward increased physician self-referral for prostate cancer treatment.

August 6, 2013

Philips gets FDA nod for rad therapy planning module

By AuntMinnie.com staff writers

Philips Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration for its Pinnacle3 proton treatment planning module.

August 4, 2013

AAPM: MRI shows early brain tumor response to treatment

By Wayne Forrest

By using dynamic contrast-enhanced MRI and diffusion-weighted MRI, physicians can determine if a brain tumor is responding to treatment as soon as two weeks into radiation therapy, according to a study presented on Sunday at the American Association of Physicists in Medicine (AAPM) annual meeting in Indianapolis.

August 4, 2013

Toshiba gets Japanese radiotherapy install

By AuntMinnie.com staff writers

Toshiba Medical Systems has received an order for its new rotating gantry irradiation system from Japan's National Institute of Radiological Sciences in Chiba.

August 1, 2013

IBA Molecular names new execs

By AuntMinnie.com staff writers

Radiopharmaceutical firm IBA Molecular has made several key additions to its U.S. management team.

August 1, 2013

GAO report points to prostate cancer IMRT self-referral

By AuntMinnie.com staff writers

A new report published by the U.S. Government Accountability Office (GAO) has linked the growth in prostate cancer-related intensity-modulated radiation therapy (IMRT) to physician self-referral.

August 1, 2013